Riskpilot← Back to searchSign inGet full accessLe Bon Group AB
ABBankruptOrg 5590433693Retail sale of medical and orthopaedic goods · NACE 4774Est. 20150 employees
Revenue 2023
SEK 107K
-63% vs 2022
EBITDA margin
-191.1%
-4025% vs 2022
Equity ratio
-354.0%
Financial strength
Net profit 2023
SEK -205K
-4057% vs 2022
| Revenue | SEK 107K | -63% |
| EBITDA | SEK -205K | -4025% |
| Net profit | SEK -205K | -4057% |
| Total assets | SEK 117K | -16% |
| Equity | SEK -413K | -98% |
| Employees | 0 | — |
Legal name
Le Bon Group AB
Org number
5590433693
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
21 december 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska driva verksamhet innefattande medicinsk fotvård, nagelbehandling liksom försälning av produkter med anknytning till dessa tjänster.Dessutom ska bolaget tillhandahålla konsulttjänster inom verksamhetsområdet. Bolaget ska därutöver sälja accesoarer. Bolaget ska även äga och förvalta fast och lös egendom inkluderande värdepapper.
Address
Email
fredrik.ruden@endsjo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 199 | 274 | 241 | 290 | 107 |
| Staff expenses | — | — | — | −1 | −8 |
| EBITDA | −27 | −71 | −160 | 5 | −205 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −27 | −71 | −160 | 5 | −205 |
| Net financials | — | — | — | −0 | 0 |
| Profit before tax | −27 | −71 | −160 | 5 | −205 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −27 | −71 | −160 | 5 | −205 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 159 | 218 | 64 | 139 | 117 |
| Equity | 17 | −54 | −213 | −208 | −413 |
| Long-term debt | 0 | 259 | 265 | 329 | 517 |
| Short-term debt | 142 | 13 | 13 | 18 | 13 |
| Total debt | 142 | 272 | 278 | 347 | 529 |
EBITDA margin
-191.1%
This company
15.8%
Market median
-1309% vs market
20192023
Equity ratio
-354.0%
This company
38.2%
Market median
-1027% vs market
20192023
Return on equity
-20451600.0%
This company
18.4%
Market median
-111150100% vs market
20192023
Net profit margin
-190.9%
This company
8.1%
Market median
-2457% vs market
20192023
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20192023
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FE Liquidator | Liquidator | 2026 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2026 | |
| Chairman | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Le Bon Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Erik Rudén | Liquidator | 0 companies |
| Nicklas Jarl Viktor Irstam | Deputy Board Member | 0 companies |
| Helene Inger Elisabet Irstam | Chairman | 0 companies |